Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use

Abstract

In postmenopausal women with overweight or obesity treated with semaglutide, HT use was associated with an improved weight loss response. This association was maintained when adjusted for confounders. Larger studies should be conducted to confirm these results.